A new study from the University of Kentucky Markey Cancer Center and the Kentucky Cannabis Center sheds light on how some cancer patients are using cannabis to manage symptoms, the benefits they report, and what that means for clinical practice.
Published in The Oncologist, the study surveyed 237 adult cancer patients who received radiation treatment between July 2023 and February 2024 at one urban and one rural oncology practice in Kentucky. Patients completed a self-guided tablet survey covering their symptoms, quality of life, financial situation, and cannabis use — including how they obtained it.
According to the University of Kentucky's news service, just over half of those surveyed said they had used unprescribed cannabis for medicinal purposes at some point in their lives. About 15% reported using cannabis after their cancer diagnosis. The most common reasons patients gave for using cannabis were pain, nausea, anxiety, and depression.
Among the 35 patients who used cannabis following a cancer diagnosis, 80% said their primary symptom improved, and nearly 89% reported an improvement in their overall quality of life. The study also found that 94% of recent cannabis users said they would be likely to discuss their use with a healthcare provider if given the chance.
Lead investigator Dr. Aradhana Kaushal, a radiation oncologist at the UK Markey Cancer Center, noted that cancer patients are already turning to cannabis for relief from symptoms related to their illness or treatment. She said the goal is to enable open conversations between patients and providers, and to ensure cancer care professionals feel equipped to answer questions and help patients make informed choices.
However, Kaushal also cautioned that the findings are based on self-reported data and do not prove that cannabis itself caused the reported improvements. "We have to be cautious about what self-reported data can tell us, and in this case, the findings don't tell us whether the cannabis itself was the reason for the reported symptom improvement," she said.
The study also highlighted a gap in physician education. Many rural radiation oncologists reported limited formal training on cannabis pharmacology. The researchers argue that more education and evidence-based clinical guidance could help clinicians better counsel patients on dosing, potential drug interactions, adverse effects, and appropriate monitoring.
Beyond the clinical findings, the study demonstrated a method for including rural patients in research. By using tablet-based surveys, the rural oncology practice was able to conduct the study without a dedicated research assistant on site. Rural patients are often underrepresented in clinical research, and this approach could help bring more rural voices into studies where staffing and resources are limited.
Kaushal said that while the findings don't confirm cannabis as the cause of symptom improvement, the approach offers a practical way to include more rural cancer patients in research and ensure their experiences are represented.
The research was funded by a UK Working in Medicine and Science booster grant and the Kentucky Cannabis Center, with additional support from the National Cancer Institute of the National Institutes of Health.